Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Raffles Medical GroupSGX:BSL 81 Days Payable is 265.71 as of Dec. 2025, which is 45% below its 10-year median of 479.09. GuruFocus rates SGX:BSL with a GF Score™ of 81/100 and a GF Value™ of S$1.06 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 606 Healthcare Providers & Services companies, Raffles Medical Group ranks better than 88.78% on this metric.
The historical rank and industry rank for Raffles Medical Group's Days Payable or its related term are showing as below:
SGX:BSL'
s Days Payable Range Over the Past 10 Years
Min: 274.49 Med: 479.09 Max: 566.79
Current: 275.18
During the past 13 years, Raffles Medical Group's highest Days Payable was 566.79. The lowest was 274.49. And the median was 479.09.
SGX:BSL's Days Payable is ranked better than 88.78% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 57.105
vs SGX:BSL: 275.18
Raffles Medical Group Days Payable Historical Data
* Premium members only.
The historical data trend for Raffles Medical Group's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Raffles Medical Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Raffles Medical Group Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Raffles Medical Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Raffles Medical Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Raffles Medical Group's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Raffles Medical Group (SGX:BSL) has a Days Payable of 265.71 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Raffles Medical Group and its competitors. This is 45% below median its historical median of 479.09. Over the past decade, Raffles Medical Group's Days Payable has ranged from 274.49 to 566.79. According to the industry distribution chart, Raffles Medical Group ranks #68 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 11.2%.
Is Raffles Medical Group's Days Payable too high?
Raffles Medical Group's current Days Payable of 265.71 is 45% below median its 10-year median of 479.09. Over the past 10 years, this metric has ranged from a low of 274.49 to a high of 566.79. The Healthcare Providers & Services industry median Days Payable is 57.11. Raffles Medical Group's value of 265.71 is 365.3% above this industry median. Based on the distribution chart, Raffles Medical Group ranks #68 out of 606 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Raffles Medical Group has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raffles Medical Group's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Raffles Medical Group ranks #68 out of 606 companies for Days Payable. This places Raffles Medical Group in the top 11% of its industry — outperforming the majority of peers. The industry median Days Payable is 57.11. Raffles Medical Group's value of 265.71 is 365.3% above this benchmark. Historically, Raffles Medical Group's own Days Payable has ranged from 274.49 to 566.79 over the past decade. While the company's 10-year median is 479.09 vs. the industry median of 57.11, Raffles Medical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.11, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Raffles Medical Group's current Days Payable of 265.71 is 365.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Raffles Medical Group and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Raffles Medical Group's current Days Payable is 265.71, which is 45% below median its own 10-year median of 479.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raffles Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Raffles Medical Group (SGX:BSL) is currently considered Modestly Undervalued. The stock's GF Value™ is S$1.06, compared to a current price of S$0.95 — trading 10.8% below its estimated fair value. The current Days Payable is 265.71, which is 45% below median its 10-year median of 479.09 and 365.3% above the Healthcare Providers & Services industry median of 57.11. Raffles Medical Group's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Raffles Medical Group (SGX:BSL), the current Days Payable is 265.71 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Raffles Medical Group (SGX:BSL) Overvalued in 2026?
Based on GuruFocus' analysis, Raffles Medical Group stock appears to be undervalued.
The current stock price of S$0.95 is trading 10.8% below its estimated GF Value™ of S$1.06.
GuruFocus considers Raffles Medical Group to be Modestly Undervalued.
Key valuation signals for SGX:BSL:
Days Payable: 265.71 (45% below median its 10-year median of 479.09)
GF Value™: S$1.06 vs. price of S$0.95 (10.8% below fair value)
Industry Position: 365.3% above the Healthcare Providers & Services median (#68 of 606)
No single metric tells the full story. See the SGX:BSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Raffles Medical Group Ltd is an integrated private healthcare provider in Asia with operations in Singapore, China, Japan, Vietnam, and Cambodia. The company owns and operates a tertiary hospital, a network of medical and dental clinics, insurance services, Japanese and Traditional Chinese Medicine clinics, and a consumer healthcare division. The company's operating segment includes Healthcare services, Hospital Services, Investment Holdings, and Insurance Services. The company generates revenue from contracts with customers, Rental Income, and Insurance revenue. Geographically operates in Singapore, Greater China, Vietnam, Cambodia and Japan.
81GF Score
Get the complete analysis for SGX:BSL
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:BSL has been successfully added to your 
